EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Cardiac Amyloidosis and SGLT2 Inhibitors: Signal, Hope, and the Need for Randomized Evidence

Humberto Villacorta, Aline Sterque Villacorta

Arquivos Brasileiros de Cardiologia · 2026-01 · 123 (1)

DOI: 10.36660/abc.20250894i ↗

Kurz gefasst

Fachartikel in der Zeitschrift Arquivos Brasileiros de Cardiologia, 2026-01. Verfasst von Humberto Villacorta und 1 weiteren Autor:innen. Die Arbeit nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Villacorta, H., & Villacorta, A. S. (2026). Cardiac Amyloidosis and SGLT2 Inhibitors: Signal, Hope, and the Need for Randomized Evidence. Arquivos Brasileiros de Cardiologia, 123(1). https://doi.org/10.36660/abc.20250894i

Vancouver

Villacorta H, Villacorta AS. Cardiac Amyloidosis and SGLT2 Inhibitors: Signal, Hope, and the Need for Randomized Evidence. Arquivos Brasileiros de Cardiologia. 2026;123(1). doi:10.36660/abc.20250894i

BibTeX
@article{Villacorta2026,
  author = {Villacorta, Humberto and Villacorta, Aline Sterque},
  title = {Cardiac Amyloidosis and SGLT2 Inhibitors: Signal, Hope, and the Need for Randomized Evidence},
  journal = {Arquivos Brasileiros de Cardiologia},
  year = {2026},
  volume = {123},
  number = {1},
  doi = {10.36660/abc.20250894i}
}
Kostenlos starten →